People with heart valve problems often worry about stroke. This fear is real because blood clots can form in the heart and travel to the brain. Many doctors have suggested closing a specific heart chamber called the left atrial appendage to prevent these clots. This procedure is called surgical left atrial appendage occlusion or SLAAO. It is usually done when patients are already having heart valve surgery. This new research asks if doing this extra step helps everyone or just specific groups of patients. The answer might change how doctors plan operations for thousands of people each year.
The study looked at 2157 patients who needed heart valve repairs or replacements. These patients had conditions like mitral or aortic valve lesions. They also had a high risk of stroke based on their health history. The researchers split them into two groups. One group received the SLAAO procedure along with their valve surgery. The other group got the standard valve surgery without closing the heart chamber. The study took place at three cardiac surgery centers in China. Everyone was followed for about 12 months after the operation.
The main goal was to see if the extra surgery prevented strokes or heart attacks. The results showed no big difference between the two groups. In the group that had the extra closure, 6.9 percent experienced a stroke, a temporary stroke, or died from heart issues. In the group that did not have the extra closure, 8.2 percent had these events. The numbers are close. The study found that the extra surgery did not significantly reduce the risk of these bad outcomes. The difference was not large enough to be considered a real benefit by the researchers.
Safety was also checked during the study. There were no serious safety concerns reported for the procedure itself. However, 39 patients stopped the study because they chose to withdraw their consent. This means some people decided they did not want to continue with the research plan. The study did not report specific side effects like bleeding or infection rates in detail. The focus remained on whether the procedure prevented the main heart and brain problems.
This study has important limits. It only looked at patients who were already having valve surgery. It did not test the procedure on people who needed it but were not having other heart operations. The follow-up time was one year. Some heart problems take longer to show up. Because of this, doctors should not change their practice based on this single study alone. The evidence is not strong enough to say the procedure is useless, but it is not clearly helpful for everyone either.
For patients right now, this means the routine use of this extra closure is not proven to help lower stroke risk in this specific group. Doctors will likely continue to use it when they think it is needed for other reasons. Patients should talk to their surgeon about their individual risks. The decision to close the heart chamber should be based on personal health needs, not just a general rule. This research helps clarify what works and what does not in heart care.